Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trial of Optimal Therapy for Pseudomonas Eradication in Cystic Fibrosis
2009-012575-10Phase 4Completed
- Sponsor
- University Hospitals Bristol and Weston NHS Foundation Trust
- Start
- Sep 2009
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ceftazidime, tobramycin, ciprofloxacin, colistin in cystic fibrosis (CF), Pseudomonal infection, sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Started Sep 2009; status: completed.
02
Drugs
ceftazidimetobramycinciprofloxacincolistin
03
Conditions
cystic fibrosis (CF)Pseudomonal infection
Beyond the preview
Go deeper on 2009-012575-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012575-10.